HMD supplies 471.35 million syringes to Govt to help vaccinate 642.5 million people

To help in vaccinating India against Covid, HMD has reserved maximum capacity for India. The company is presently not accepting any export orders from many overseas potential buyers

New Delhi: Hindustan Syringes and Medical Devices Limited (HMD), one of the leading manufacturers of disposable syringes, has supplied 471.35 million pcs to Government of India by September 2021 end to help vaccinate 642.5 million people.
“India’s vaccination drive has been a role model for the world. We congratulate the Indian Government & we are glad we could shoulder the responsibilities with the Govt. for the success of India’s massive vaccination campaign, while balancing needs for seasonal spike of Dengue and Typhoid,” said Mr. Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd.
“To ensure there is no shortage of syringes, HMD has preponed the supply commitments to the Ministry of Health and Family Welfare and against 442.5 million pcs committed by Sep, HMD has already supplied 471.35 million pcs. An additional 13 million pcs are also on the way. Govt. of India has entrusted HMD with a new order of 132.5 mn pcs & HMD has further diverted the supply of 100 million pcs from UNICEF order to GoI from Sept to Dec. Spike in demand for Non-Covid healthcare has also posed challenges for Vaccination Syringes,” said Mr. Rajiv Nath.
“In our utmost endeavour to make India Covid syringe surplus, in August HMD has achieved production capacity of over 1 Billion AD syringes for Covid vaccination per year, helping make India Atmanirbhar in syringe manufacturing. Presently HMD is producing more than 4.2 lakh syringes of various types per hour at our factories spread over 11 acres in Faridabad industrial district in Haryana,” stated Mr. Rajiv Nath.
Mr. Nath further stated that HMD is in a position and well equipped to export non-covid syringes mainly for children for Yellow Fever or Measles, Hepatitis B, Pentavalent or BCG etc. This is India’s and HMD’s ongoing global contractual commitments to support global immunization projects.However HMD’s top priority right now is to ensure there is no syringe shortage in India to help the Govt. to combat the pandemic.
Highlighting the role played by HMD to help in vaccinating India against Covid, Mr. Nath shared “Amidst the alarming covid situation, our manufacturing plants were operational 24/7 and acted as a backbone to the Indian Healthcare sector and the frontline workers.  In April 2020 itself, we started to rapidly ramped up HMD’s capacity and re-engineered the standard Disposables Syringes lines to manufacture in their place Auto Disable Syringe for vaccination. HMD initiated in May an investment of over 15 Million dollars (approx. 100 Cr Rs.) from their own resources, without govt. support to mass produce Specialty syringes even before Purchase orders were even in sight.”
From 50 Crore (500 mn) pcs per annum capacity of 0.5 ml AD Syringes in June 2020, we increased production rate to 80 Crore (800 mn) pcs per annum in May 2021 & currently we have achieved our target capacity of producing 100 crore (1 billion)  Auto Disable syringes per annum to support the massive vaccination campaign to eradicate Covid-19, & next hopefully125 Crore (1.25 bn) pcs per annum by March 2022. HMD has also scaled assorted syringes production to 300 crore (3 bn) and more, in their sincere quest for ensuring no shortages in India.
To help in vaccinating India against Covid, HMD has reserved maximum capacity for India. The company is presently not accepting any export orders from many overseas potential buyers.
“HMD had been ensuring continuity of supply chain and its manufacturing plants in its sincere quest to ensure India faces no shortages for its critically needed disposable syringes for covid vaccination. HMD extends full cooperation & support to GoI and will do whatever it needs to produce syringes ahead of schedule to ensure success of India’s massive vaccination campaign,” Mr. Nath concluded.